<DOC>
	<DOCNO>NCT02652156</DOCNO>
	<brief_summary>This clinical trial examine difference effectiveness three ( 3 ) commonly use method and/or medication use perform transversus abdominis plane ( TAP ) block post-operative pain control . The transversus abdominis muscle either side low rib hip bone . Group A subject undergo post-operative pain relief treatment single injection Bupivacaine inject TAP . Group B subject undergo post-operative pain relief treatment single injection Exparel® , liposomal form bupivacaine TAP . Group C subject treat continuous infusion local anesthetic ropivacaine ON-Q® pump . There placebo group study .</brief_summary>
	<brief_title>TAP Block Postoperative Pain Control</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Ability give write informed consent Scheduled open abdominal surgery American Society Anesthesiologists physical status 1 3 Inability understand study provide write informed consent Inability follow protocol instruction Complicated history chronic opioid use include daily use opioids period great 2 week prior surgery Allergy local anesthetic agent Contraindication regional nerve block : Bleeding disorder Sepsis Infection site block Body Mass Index ( BMI ) &gt; 40 Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>transversus abdominis plane</keyword>
	<keyword>postoperative</keyword>
	<keyword>pain</keyword>
</DOC>